Next Article in Journal
Antioxidant Activity of Pharmaceuticals: Predictive QSAR Modeling for Potential Therapeutic Strategy
Next Article in Special Issue
Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century
Previous Article in Journal
Differential Effects of a Novel Opioid Ligand UTA1003 on Antinociceptive Tolerance and Motor Behaviour
Previous Article in Special Issue
Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(7), 792; https://doi.org/10.3390/ph15070792
Action Date Notes Link
article xml file uploaded 24 June 2022 15:00 CEST Original file -
article xml uploaded. 24 June 2022 15:00 CEST Update -
article pdf uploaded. 24 June 2022 15:00 CEST Version of Record https://www.mdpi.com/1424-8247/15/7/792/pdf-vor
article supplementary file uploaded. 24 June 2022 15:00 CEST - https://www.mdpi.com/1424-8247/15/7/792#supplementary
article html file updated 24 June 2022 15:02 CEST Original file -
article xml file uploaded 28 June 2022 04:55 CEST Update -
article xml uploaded. 28 June 2022 04:55 CEST Update https://www.mdpi.com/1424-8247/15/7/792/xml
article pdf uploaded. 28 June 2022 04:55 CEST Updated version of record https://www.mdpi.com/1424-8247/15/7/792/pdf
article html file updated 28 June 2022 04:57 CEST Update -
article html file updated 12 August 2022 22:19 CEST Update https://www.mdpi.com/1424-8247/15/7/792/html
Back to TopTop